Background: Spontaneous intestinal perforation (SIP) is increasingly common in the premature infant and has been demonstrated to be associated with early postnatal administration of glucocorticoids and indomethacin. Before survival of the extremely low birth weight (ELBW) infant, SIP was thought to be a rare, congenitally acquired disease sporadically affecting the muscularis of the distal intestine. These disparate views of etiology have not been previously reconciled in the literature.
Introduction
Spontaneous intestinal perforation (SIP), also known as focal small bowel perforation, is an acquired form of neonatal bowel disease that is distinct from necrotizing enterocolitis (NEC). However, distinguishing SIP from NEC in large clinical databases has been challenging. We recently created the first national database devoted to SIP investigation. 1 In the first study using this data set, we demonstrated that early postnatal indomethacin was independently associated with SIP, thereby addressing one of the more controversial topics in the SIP literature. [1] [2] [3] [4] In this second study, we sought to address another inconsistency in the SIP literature. Before the improved survival of ELBW infants, SIP was thought to be a congenitally acquired disease that affects term and near term infants (old SIP). [5] [6] [7] These case reports described segmental absence of the muscularis in the distal intestine either as an isolated or multifocal process, with some infants having a single occurrence and others having recurrent presentations. The difference in presumed etiology between the old SIP and the new SIP has never been resolved but reports of the old SIP have declined in recent years. This has resulted in a tacit presumption by many clinicians that there is only one form of SIP. The size of our SIP cohort provided a method to differentiate between the two patient populations acquiring each form of SIP, thereby allowing us to determine differences in prevalence and demographics. Our hypothesis was that there are two distinct forms of SIP.
Methods
The deidentified administrative data set Clinical data on these neonates was recorded during the time that care was being provided in the NICU as described previously.
Admission, discharge and daily progress notes were generated using a computer-assisted tool, and the data were stored in an electronic database. These data were consolidated within the Pediatrix data warehouse where they were deidentified, made HIPAA-compliant, and configured into tables that can be joined and queried for statistical analyses. The use of the data reported here and certification of the data as deidentified was approved by the University of Virginia Human Investigation Committee (Charlottesville, VA, USA) and the Wichita Medical Research and Education Foundation (Wichita, KS, USA).
The study cohort
We assembled a retrospective cohort of neonates from the Pediatrix deidentified administrative data set in order to compare neonates diagnosed with perforated intestines to a control group. This was accomplished by searching for all reports of 'perforated bowel,' 'ileal perforation,' and/or 'isolated perforation of the bowel' within specific tables: 'Patients,' 'Admissions,' 'Medications,' and 'Diagnoses.' It became quickly apparent that a distinctive group of neonates was present in this data set -those with bowel perforation and a report of a major anomaly (and these patients were excluded from subsequent analyses). Those that remained were pooled into the SIP patient cohort as described previously. 1 Temporal subset analysis Day of diagnosis was used as a unique data element to test for temporal associations between pharmacologic associations identified by multivariate analysis in our previous study and the literature to be significant for SIP. 1 The SIP cohort was then sorted according to timing of drug exposures during the first 2 weeks of life to examine timing of drug effect. Comparisons were evaluated by t-test and standard deviation to assess differences in the mean and distribution of diagnosis timing.
Univariate analysis
Study populations were compared using univariate techniques. Continuous variables (estimated gestational age and birth weight) were evaluated with two-tailed t-tests. Categorical variables (e.g., race and gender) were evaluated with a two-tailed w 2 test. Nonparametric continuous data were assessed with a KruskalWallis analysis of variance.
Results
Creation of the data set Between January 1, 1996, and June 1, 2004, care was provided by clinicians affiliated with Pediatrix to 227 711 neonates. Using search techniques, we identified 739 patients with a report of SIP. Neonates with reports of gastric perforation and major congenital anomalies were excluded from this cohort. Major anomalies associated with a report of bowel perforation were: heart anomalies, cystic fibrosis, gastroschisis, intestinal atresia, Hirschsprung disease, chromosomal abnormality, multiple congenital anomalies, galactosemia, hydrops fetalis, omphalocele, thalassemia, and diaphragmatic hernia (total excluded ¼ 106). These exclusions left a total of 633 patients with SIP. 1 Analysis of SIP cohort using timing of diagnosis as a unique data element All patients diagnosed with SIP during the first 15 days of life (which comprised 79% of the total cohort (502 patients)), were plotted by day of diagnosis versus percent of the total cohort ( Figure 1 ). This revealed a bimodal distribution in SIP presentation with approximately 1/5th of the total cohort presenting in days 0-3 and the remainder presenting in days 4-14. Simultaneous plotting of the percentage of patients who first received indomethacin or glucocorticoids revealed administration of the drugs almost exclusively within the 0-3 day window, illustrating a poor fit between the curves for drug administration and timing of diagnosis.
The cohort was subdivided according to whether or not they received indomethacin, glucocorticoids, both or neither during the 0-3 day window and then contrasted in aggregate (Figure 2) . From this analysis, we found that the untreated cohort was diagnosed significantly earlier on average than each of the three treated cohorts (P<0.005). Figure 1 Graph demonstrating the temporal characteristics of our SIP subcohort. The bold black squares represent the percentage of the cohort diagnosed with SIP on each day (note an early peak of incidence in days 0-3 and a major peak from days 6 to 9). The open triangles represent the percentage of the cohort that received indomethacin on each day. The black circles represent the percentage of the cohort that received glucocorticoid (either hydrocortisone or dexamethasone) on each day. The dotted line represents the end of the early window. The dashed line represents the point at which we truncated the data set, limiting it to the cases within the early and major peaks of presentation (79% of the total). A bimodal distribution in SIP incidence is evident, but only a single window of postnatal drug exposure exists (days 0-3).
As the majority of untreated SIP patients appeared to be within the early peak of presentation, we divided our SIP cohort into early (days 0-3) and late (days 4-14) presentation to investigate these two highly contrasting populations by univariate analysis (Table 1) . We found that the early SIP patients were significantly older, larger birth weight infants that were less likely to require ventilator support. These infants were also significantly more likely to be male and not to have received antenatal steroids.
Discussion
By using day of diagnosis as a unique data variable, we were able to delineate within a national database two distinct populations of patients who acquire SIP. More than three quarters of the SIP cases in this refined cohort were found in ELBW infants who had a corresponding window of postnatal drug exposure. However, the remainder of this cohort had no reported postnatal risk factors and consisted of an older gestation, larger birth weight subset of infants that presented in days 0-3. Before the realization that extreme prematurity, steroids and indomethacin were risk factors for SIP, the surgical literature contained reports of a congenital absence of the muscularis as the presumed etiology for intestinal perforations in near term infants. 5 As evidence for this hypothesis, previous authors had noted the same pathologic findings subsequently found in SIP of the ELBW infant. 6, 7 Our ability to capture this subset of patients, who are significantly more likely to be male and seem to have perforations in transit out of the womb, reinvigorates the postulate that SIP can be acquired congenitally.
It is unclear whether these early perforations represent a genetic or a teratogenic event, as we now know with reasonable certainty that the ELBW form of SIP is acquired. Recent epidemiologic investigations have shown nonsteroidal antiinflammatory drug (NSAID) use approaching 20% of all pregnant women and we have recently demonstrated an association between the postnatal administration of one such NSAID (indomethacin) and SIP found in the ELBW infant . 1, 9 It is tempting to speculate that, just as there seems to be a postnatal window of vulnerability for SIP in ELBW infants to NSAIDs, there might also be a critical window of vulnerability to NSAIDs in utero.
Our findings have important implications for past and future studies of SIP. Prospective trials limited to the ELBW population should only detect late onset SIP related to postnatal risk factors. Surgical studies employing serial enrollment of isolated perforations should contain mixed populations, although these cohorts can be retrospectively divided by their birth weights (above and below 1000 g) and crossvalidated with the time of perforation. All studies will need to pay close attention to categorical weight cutoffs when assessing SIP as a secondary outcome.
Finally, SIP can no longer be considered a rare disease. Based on the number of cases in this data set, the estimated incidence of SIP is 1:5000 live births. We calculated this by assuming that all Pediatrix admissions are preterm (a conservative bias) and then extrapolating this to a theoretical representation of total live births by dividing by 0.07 (the incidence of prematurity in the United States). We then took the total number of cases of SIP pulled from our database and divided it by the calculated number of total births. To put this in perspective, SIP is more common than cystic fibrosis in its incidence.
In summary, we have delineated two forms of SIP that differ in their timing of presentation and occur in two distinct gestational populations of preterm neonates. Further research is required to understand the etiologic distinctions between the two disease presentations.
Abbreviations SIP, spontaneous intestinal perforation; ELBW, extremely low birth weight; NEC, necrotizing enterocolitis.
